Literature DB >> 20520984

Robotic rectosigmoidectomy - pioneer case report in Brazil. Current scene in colorectal robotic surgery.

Marcelo Averbach1, Pedro Popoutchi, Oswaldo Wiliam Marques, Ricardo Z Abdalla, Sérgio Podgaec, Maurício Simões Abrão.   

Abstract

Laparoscopic colorectal surgery is believed to be technically and oncologically feasible. Robotic surgery is an attractive mode in performing minimally-invasive surgery once it has several advantages if compared to standard laparoscopic surgery. The aim of this paper is to report the first known case of colorectal resection surgery using the robotic assisted surgical device in Brazil. A 35-year-old woman with deep infiltrating endometriosis with rectal involvement was referred for colorectal resection using da Vinci surgical system. The authors also reviewed the most current series and discussed not only the safety and feasibility but also the real benefits of robotic colorectal surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20520984     DOI: 10.1590/s0004-28032010000100018

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  4 in total

Review 1.  Robotic colorectal surgery: summary of the current evidence.

Authors:  E H Aly
Journal:  Int J Colorectal Dis       Date:  2013-09-01       Impact factor: 2.571

2.  Application of robotics in adnexal surgery.

Authors:  Olga A Tusheva; Antonio R Gargiulo; Jon I Einarsson
Journal:  Rev Obstet Gynecol       Date:  2013

3.  Robotic-assisted hysterectomy for the management of severe endometriosis: a retrospective review of short-term surgical outcomes.

Authors:  Mohamed A Bedaiwy; Mohamed Y Abdel Rahman; Mark Chapman; Heidi Frasure; Sangeeta Mahajan; Vivian E von Gruenigen; William Hurd; Kristine Zanotti
Journal:  JSLS       Date:  2013 Jan-Mar       Impact factor: 2.172

4.  Perioperative outcomes of robotic assisted laparoscopic surgery versus conventional laparoscopy surgery for advanced-stage endometriosis.

Authors:  Farr R Nezhat; Ido Sirota
Journal:  JSLS       Date:  2014 Oct-Dec       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.